Cargando…
Development and Evaluation of a Novel Pellet-Based Tablet System for Potential Colon Delivery of Budesonide
Budesonide, a potent glucocorticoid, is used for the treatment of inflammatory bowel diseases. Current available oral formulations of budesonide have low efficacy against ulcerative colitis because of the premature drug release in the upper part of the gastrointestinal tract. In this paper a pH- and...
Autores principales: | Varshosaz, Jaleh, Emami, Jaber, Tavakoli, Naser, Minaiyan, Mohsen, Rahmani, Nakisa, Dorkoosh, Farid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346988/ https://www.ncbi.nlm.nih.gov/pubmed/22577558 http://dx.doi.org/10.1155/2012/905191 |
Ejemplares similares
-
Pectin Film Coated Pellets for Colon-targeted Delivery of Budesonide: In-vitro/In-vivo Evaluation in Induced Ulcerative Colitis in Rat
por: Varshosaz, Jaleh, et al.
Publicado: (2012) -
Colon Delivery of Budesonide Using Solid Dispersion in Dextran for the Treatment and Secondary Prevention of Ulcerative Colitis in Rat
por: Varshosaz, Jaleh, et al.
Publicado: (2010) -
Development of novel budesonide pellets based on CODES(TM) technology: In vitro/in vivo evaluation in induced colitis in rats
por: Varshosaz, J., et al.
Publicado: (2011) -
Development and validation of a rapid HPLC method for simultaneous analysis of budesonide and its novel synthesized hemiesters in colon specific formulations
por: Varshosaz, J., et al.
Publicado: (2011) -
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model
por: Eskandari, Sharareh, et al.
Publicado: (2011)